Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

National Health Research Institutes
National Health Research Institutes_20100107
National Health Research Institutes_20100114
National Health Research Institutes_20100128
National Health Research Institutes_20131212
  

National Health Research Institutes patents

Recent patent applications related to National Health Research Institutes. National Health Research Institutes is listed as an Agent/Assignee. Note: National Health Research Institutes may have other listings under different names/spellings. We're not affiliated with National Health Research Institutes, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | National Health Research Institutes-related inventors




Date National Health Research Institutes patents (updated weekly) - BOOKMARK this page
10/26/17Method for determining deletions in hbv pre-s2 region
09/14/17Endotoxin nanovesicles: hydrophilic gold nanodots control lipopolysaccharide assembly for modulating immunological responses
09/07/17Thiazolidinone compounds and use thereof
08/31/17Methods to upregulate and suppress an expression of immunomodulatory cells
08/31/17Progenitor cells, preparation thereof and uses thereof
08/10/17Methods to enhance nerve regeneration utilizing neural stem cells and il12p40
08/10/17Aminothiazole compounds
05/25/17Microfluidic dual-well device for highthroughput single-cell capture and culture
03/02/17Opioid receptor modulators and use thereof
03/02/17Adenoviral vector-based vaccine against enterovirus infection
03/02/17Histone deacetylase inhibitors
02/09/17Use of known compounds as d-amino acid oxidase inhibitors
11/03/16Artificial tears solution combination
06/30/16Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy
06/16/16Cpg-oligodeoxynucleotide, immunogenic composition comprising the same, and methods for preparing the composition and stimulating immune response thereby
03/31/16Methods of prognostically classifying and treating glandular cancers
03/24/16Heterocyclic compounds and use thereof
11/26/15Dipicolylamine derivatives and their pharmaceutical uses
07/09/15Molecular markers for prognostically predicting prostate cancer, method and kit thereof
07/09/15Specimen preparation for transmission electron microscopy
07/02/15Alpha-enolase specific antibodies and methods of uses in cancer therapy
03/12/15Antibodies and determining deletions in hbv pre-s2 region
09/18/14Compositions and methods for treating clostridium difficile-associated diseases
08/21/14Caged platinum nanoclusters for anticancer chemotherapeutics
07/31/14Recombinant bcg strains with enhanced ability to inhibit intracellular mycobacterial growth
06/26/14Mesoporous silica nanoparticles for oil absorption
06/12/14Primers, snp markers and genotyping mycobacterium tuberculosis
04/17/14Method and system for destroying adipose tissue non-invasively and accelerating lipid metabolism
03/13/14Method for generating immunomodulatory cells, the cells prepared therefrom and use thereof
03/13/14Pharmaceutical composition and methods for peptide treatment
02/27/14Immunosuppressive cells and methods of making and using thereof
02/20/14Methods for detecting hepatitis b virus surface gene non-sense mutations
12/12/13Molecular markers for prognostically predicting prostate cancer, method and kit thereof
08/22/13Methods for improving sensitivity and specificity of screening assays of kras codons 12 and 13 mutations
06/27/13Methods and compositions for cellular drug release
06/20/13Novel glycoside compounds
05/09/13Recombinant bcg strains with enhanced ability to inhibit intracellular mycobacterial growth
04/04/13Microfluidic hanging drop chip
04/04/13Pyrazole compounds
01/17/13Map kinase kinase kinase kinase 3 (map4k3) as a biomarker and therapetic target for autoimmune disease, cancer, inflammation and il-17-associated disease
12/27/12Multi-phase emulsions based on amphiphilic block copolymers
09/06/12Pyrazole compounds and thiazole compounds as protein kinases inhibitors
09/06/12Single-monomer derived linear-like copolymer comprising polyethylenimine and poly(ethylene glycol) for nucleic acid delivery
06/07/12F1b-tmir plasmid vector and transgenic mouse
05/24/12Solid phase gold nanoparticle synthesis
05/17/12Lipidated polyepitope vaccines
05/17/12Method of producing lipidated polypeptides
05/17/12Multiple-frequency ultrasonic phased array driving system
03/01/12One-pot synthesis of linear-like polyethylenimine for intracellular imaging and nucleic acid delivery
02/23/12Immunogenic compositions and uses thereof
02/23/12Coumarin compounds and their use for treating viral infection
02/16/12Preparation and purification of subunit vaccine for neisseria meningitidis (nm) group b isolates
10/27/11Quinoline compounds and their use for treating viral infection
10/13/11Gamma-polyglutamic acid-based ocular irrigating solutions
10/13/11Lipoic acid metabolite conjugate: preparation and their therapeutic effect
09/22/11Recombinant construct for detection of halogenated aromatic hydrocarbons
08/18/11Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
07/28/11Cisd2-knockout mice and uses thereof
07/14/11Dibenzo[f,h]isoquinoline derivatives
07/07/11Cathepsin s inhibitors
07/07/11Receiving surface coils used during thermal ablation procedure
06/09/11Proline derivatives
05/26/11Transgenic animal with monocyte chemotactic protein 1 promoter
03/03/11Multi-phase emulsions based on amphiphilic block copolymers
03/03/11Controlled release multidrug formulations for spinal cord injury
Patent Packs
02/17/11Immunogenic peptides of tumor associated antigen l6 and uses thereof in cancer therapy
02/10/11Dual-curvature phased array high-intensity focused ultrasound transducer for tumor therapy
01/27/11F1b-tmir plasmid vector and transgenic mouse
01/20/11Human respiratory syncytial virus (rsv) vaccine
12/23/10Lipidated tumor-associated antigens and immunotherapeutic compositions
12/02/10Lipidated vaccine against dengue virus infection
10/28/10Polyvalent chimeric rubella virus-based vaccines
09/16/10Pyrrolidine compounds
09/16/10Non-human animal model for lung carcinoma
08/26/10Phenanthroindolizidine analogues
07/08/10Hla-a2-restricted t-cell epitopes of the respiratory syncytial virus fusion protein as peptide-based vaccines
07/01/10Adjuvants
05/13/10Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
05/06/10Imidazol-4-one and imidazole-4-thione compounds
04/01/10Fused multicyclic compounds as protein kinase inhibitors
Patent Packs
03/18/10Implantable nerve regeneration conduit
01/28/10Functionalized quantum dots and methods for preparing them
01/14/10Anticancer oral formulation
01/07/10Diagnosis of nasopharyngeal carcinoma and suppression of nasopharyngeal carcinoma invasion
01/07/10Oligonucleotides and use thereof for determining deletion in hbv pre-s region
12/17/09Coumarin compounds and their use for treating cancer
11/26/09Methods and compostions for enhancing transdermal drug delivery
11/05/09Red blood cell-derived vesicles as a nanoparticle drug delivery system
11/05/09Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/09Treatment of neurodegenerative disorders with thiourea compounds
09/24/09Lung cancer diagnosis based on expression levels of gimap genes
09/10/09Pyrrolidine derivatives
09/03/09Rapid efficacy assessment lung cancer therapy
09/03/09Lipidating sequences and use thereof for producing lipidated proteins in e. coli
08/06/09Cancer treatment
07/09/09Production of lipidated proteins in e. coli
07/09/09Imidazolidinone and imidazolidinethione derivatives
07/02/09Positioning system for thermal therapy
06/18/09Methods and compositions relating to expression factors
05/07/09Immunopeptides of hpv e6 and e7 proteins
04/30/09Generating gating signals for thermal therapy
03/26/09Cancer therapy
12/12/13Molecular markers for prognostically predicting prostate cancer, method and kit thereof
01/28/10Functionalized quantum dots and methods for preparing them
01/14/10Anticancer oral formulation
01/07/10Oligonucleotides and use thereof for determining deletion in hbv pre-s region







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with National Health Research Institutes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for National Health Research Institutes with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';